Markets for the most part have held up. There are a couple of weak areas. The NQ has lagged both the...
Big Drug Stock Set Up at Key Level
01/26/2012 9:00 am EST
An early-year decline has taken shares of drug maker Eli Lilly & Co. (LLY) to strong moving average support, potentially in advance of a new run to higher prices. If support holds, here’s how to play it.
It’s been a tough start in 2012 for Eli Lilly & Co (LLY). The drug maker enjoyed a nice holiday season in December after slowly rising through the summer and testing its 200-day moving average (MA) multiple times.
LLY now sits carefully at its 50-day moving average, which appears to be holding as support. The MACD appears that it may just ever-so-slightly be starting to flatten, and the CCI indicator has been bouncing off the lower line, confused, it seems, about which direction to go confidently.
Learn more: Demystifying the MACD Indicator
Should the 50-day moving average hold as support, I would look for LLY to make a move toward the previous high in the area of $42. A stop just below the 50-day moving average ($38.90 for conservative traders and $38 for more aggressive traders) would be warranted.
By Tim Bourquin, co-founder, The Traders Expo
Tim will be moderating several panel discussions at February’s New York Traders Expo.
Related Articles on STOCKS
All that need be said trade is that if China retaliates and Trump doubles-down in respect to new tar...
Shares of San Diego-based Kratos Defense & Security Solutions (KTOS) had a rocky start to 2018. ...
My new book, Rule 1 of Investing: How to Always be on the Right Side of the Market, was just release...